Increase in Breast Cancer Stem Cells in Response to Prostaglandin E2. Revision

2010 ◽  
Author(s):  
Monica Liebert
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Prostaglandin E2 ◽  
Breast Cancer Stem Cells

scholarly journals Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity

Oncotarget ◽  
2017 ◽  
Vol 8 (70) ◽  
pp. 115254-115269 ◽  
Author(s):  
Chaolin Huang ◽  
Yuanhong Chen ◽  
Hang Liu ◽  
Jing Yang ◽  
Xuejing Song ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Prostaglandin E2 ◽  
Wnt Pathway ◽  
Breast Cancer Stem Cells ◽  
Pathway Activity

scholarly journals Author Correction: Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Sandra Marijan ◽  
Anita Markotić ◽  
Angela Mastelić ◽  
Nikolina Režić-Mužinić ◽  
Lisa Ivy Pilkington ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Breast Cancer Stem Cells ◽  
Anticancer Compound

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Sign in / Sign up

Export Citation Format

Share Document